At Velocity Clinical Research, we’re proud to be one of the largest clinical trial patient networks in the world, with access to over one million patients in our database across more than 70 integrated sites. That scale puts us in a unique position to listen, learn, and lead—and it’s why we’re excited to share insights from our latest nationwide patient survey.
This year’s report—From Motivation to Misinformation: How Patient Recruitment is Changing—captures the evolving experiences and perceptions of clinical trial participants across the U.S. Our findings reveal important shifts since our last survey in 2022, highlighting not only what motivates patients to join studies but also how social factors, support networks, and the spread of misinformation shape their willingness to participate.
Key takeaways?
- Younger adults are increasingly hesitant to engage in clinical trials, even as older adults remain motivated by altruism.
- Community support (or the lack thereof) plays a critical role in how patients experience trials—and in whether they talk about their involvement at all.
- Misinformation is emerging as a major barrier, with social media being the most cited source.
As an industry, we can’t afford to ignore these trends. That’s why at Velocity, we’re committed to turning insights into action—strengthening patient engagement strategies, empowering sites, and helping sponsors reach the right patients at the right time.
We invite you to dive into the full survey findings to learn how we’re using these insights to shape the future of patient recruitment. Let’s work together to build a research ecosystem that’s accessible, trusted, and patient-centered.
Read the report here: Patient Engagement in Clinical Trials 2025: From Motivation to Misinformation
Have questions? Connect with our team: feasibility@velocityclinical.com.
